| Drug-resistant epilepsy: multiple hypotheses, few answers F Tang, AMS Hartz, B Bauer Frontiers in neurology 8, 301, 2017 | 440 | 2017 |
| Rational clinical dose selection of adeno‐associated virus‐mediated gene therapy based on allometric principles F Tang, H Wong, CM Ng Clinical Pharmacology & Therapeutics 110 (3), 803-807, 2021 | 26 | 2021 |
| Population pharmacokinetics of exendin‐(9‐39) and clinical dose selection in patients with congenital hyperinsulinism CM Ng, F Tang, SH Seeholzer, Y Zou, DD De León British Journal of Clinical Pharmacology 84 (3), 520-532, 2018 | 18 | 2018 |
| First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers F Tang, R Kunder, T Chu, A Hains, A Nguyen, JM McBride, Y Zhong, ... Clinical and Translational Science 16 (9), 1653-1666, 2023 | 13 | 2023 |
| Validation of a HPLC/MS method for simultaneous quantification of clonidine, morphine and its metabolites in human plasma F Tang, H Bada, CM Ng, M Leggas Biomedical Chromatography 33 (7), e4527, 2019 | 11 | 2019 |
| Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments F Tang, CM Ng, HS Bada, M Leggas Clinical and Translational Science 14 (4), 1231-1249, 2021 | 6 | 2021 |
| Parametric time‐to‐event model for acute exacerbations in idiopathic pulmonary fibrosis F Tang, B Weber, S Stowasser, J Korell CPT: Pharmacometrics & Systems Pharmacology 9 (2), 87-95, 2020 | 4 | 2020 |
| Pharmacokinetic modeling of the blood‐stable camptothecin analog AR‐67 in two different formulations X Liu, E Adane, F Tang, M Leggas Biopharmaceutics & Drug Disposition 40 (8), 265-275, 2019 | 4 | 2019 |
| Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors F Tang, E Tsakalozou, SM Arnold, CM Ng, M Leggas Investigational new drugs 37, 1218-1230, 2019 | 3 | 2019 |
| A Modified Hybrid Wald’s Approximation Method for Efficient Covariate Selection in Population Pharmacokinetic Analysis Y Zou, F Tang, CM Ng The AAPS Journal 23, 1-13, 2021 | 2 | 2021 |
| Population pharmacokinetics of tenecteplase in patients with acute myocardial infarction and application to patients with acute ischemic stroke F Tang, J Langenhorst, S Dang, N Kassir, R Owen, B Purdon, ... The Journal of Clinical Pharmacology 63 (2), 197-209, 2023 | 1 | 2023 |
| Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer Y Zou, F Tang, JC Talbert, CM Ng Plos one 15 (3), e0230571, 2020 | 1 | 2020 |
| A Novel Modified Wald's Approximated Method for Efficient Covariate Selection in Population Pharmacokinetics Analysis Y Zou, F Tang, CM Ng JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S75-S75, 2017 | 1 | 2017 |
| Human Pharmacokinetic and CYP3A DDI Prediction of GDC-2394 using PBPK Modeling and Biomarker Assessment J Yu, F Tang, F Ma, S Wong, J Wang, J Ly, L Chen, J Mao Drug Metabolism and Disposition, 2024 | | 2024 |
| Population Pharmacokinetic Modeling and Genetic Association Analysis in Infants with Neonatal Abstinence Syndrome Receiving Morphine Or Clonidine F Tang | | 2020 |
| Using Novel Monte-Carlo Parametric Expectation Maximization Based Wald's Approximation Method with Backward Elimination to Develop Disease Progression Model for Metastatic … Y Zou, F Tang, JC Talbert, CM Ng JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S75-S76, 2017 | | 2017 |
